Recreational users of gamma-hydroxybutyrate (GHB) typically take somewhere in the range of one to three grams as a single oral dose, but that figure comes with a critical caveat: the margin between the amount that produces euphoria and the amount that can cause a coma or death is alarmingly small. One comprehensive pharmacology review flatly states that “the recreational dose of GHB is not easy to estimate,” in part because the drug’s concentration varies wildly from batch to batch and individual responses differ by body weight, tolerance, and stomach contents.1PubMed Central. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome Understanding how researchers have studied these doses, and why the drug behaves the way it does, matters for anyone trying to make sense of GHB’s unusual risk profile.
What Controlled Studies Have Actually Tested
Relatively few controlled human trials exist for GHB at recreational-range doses, because the drug’s steep dose-response curve makes higher doses ethically tricky to administer in a lab. One early pharmacokinetic study gave eight healthy, GHB-naive volunteers a single oral dose of 25 milligrams per kilogram of body weight. For a person weighing around 70 kilograms (roughly 154 pounds), that works out to about 1.75 grams. Even at that moderate dose, plasma concentrations peaked within 20 to 45 minutes and varied substantially between participants.2Journal of Analytical Toxicology. Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects
A separate laboratory study tested a wider range, from 0.32 grams up to 3.2 grams per 70 kilograms of body weight, in participants with no history of sedative misuse. Across that range, the drug produced dose-related increases in sedation, dissociative feelings, positive mood, and stimulant-like effects. At lower doses, participants reported mild relaxation and sociability; at the upper end, sedation dominated. Psychomotor performance and blood pressure stayed relatively stable across all tested doses, which is part of why users can feel functional at lower amounts and then tip into unconsciousness as the dose edges upward.3PubMed Central. Behavioral Effects of Gamma-Hydroxybutyrate (GHB) in Humans
These studies paint a picture of a drug whose effects ramp up quickly across a fairly narrow dose window. The lower end of the recreational range, around one gram, sits near what labs have been comfortable giving volunteers. The upper end, around three grams, approaches the zone where sedation becomes difficult to control and the risk of losing consciousness rises sharply.
Why Getting the Dose Right Is So Difficult
GHB on the illicit market is almost always sold as a liquid, and the concentration of that liquid can vary enormously. A capful from one source might contain half a gram of GHB; a capful from another might contain three grams. Unlike a pharmaceutical tablet with a fixed milligram count, there is no reliable way for a user to know how much active drug is in any given batch without laboratory analysis. This is the single largest driver of accidental overdoses: people dose by volume (“one capful” or “one sip”) rather than by weight, and that volume tells them almost nothing about how much drug they are actually swallowing.
Body weight also matters. Since studies dose GHB by milligrams per kilogram, a person weighing 55 kilograms and one weighing 100 kilograms would need substantially different absolute amounts to reach the same plasma concentration. Stomach contents play a role too. GHB absorbs rapidly on an empty stomach, producing a sharper, higher peak in the blood, while food in the stomach can slow absorption and blunt that peak somewhat. These variables interact, meaning the “right” dose for the same person can shift from one occasion to the next.
The Thin Line Between Euphoria and Overdose
What makes GHB especially dangerous compared to many other recreational drugs is the steepness of its dose-response curve. A plasma concentration of roughly 100 milligrams per liter is associated with the effects users are seeking: euphoria, disinhibition, a feeling of relaxation and sociability. But a plasma concentration of around 500 milligrams per liter can cause death from cardiorespiratory depression.1PubMed Central. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome That is only about a fivefold difference between a pleasurable dose and a potentially fatal one. For comparison, the margin between a therapeutic and a lethal dose is much wider for many other substances people encounter.
This narrow therapeutic window means that even a modest miscalculation, taking two grams instead of one, or taking one gram from a batch that turns out to be twice as concentrated as expected, can push a person from feeling good to losing consciousness. Emergency departments that see GHB cases report that patients often arrive deeply sedated or comatose, sometimes with depressed breathing, and the transition from “feeling fine” to “unresponsive” can happen over a span of minutes.
How Quickly GHB Acts and Clears the Body
GHB is absorbed remarkably fast. After a single oral dose, blood concentrations reach their peak within about 20 to 40 minutes.1PubMed Central. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome A placebo-controlled clinical trial found a median peak blood concentration of about 50 micrograms per milliliter occurring roughly one hour after intake, though there was wide individual variation, with peaks ranging from 17 to 71 micrograms per milliliter across participants.4PubMed Central. Endogenous Levels, Detection Time, and Symptoms of Gamma‐Hydroxybutyric Acid: Results From A Placebo‐Controlled Clinical Trial
Once it peaks, GHB also leaves the bloodstream quickly. The elimination half-life is only about 30 to 50 minutes, meaning blood levels drop by half roughly every half hour to hour.1PubMed Central. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome This rapid rise-and-fall pattern gives the drug a notably short duration of action compared to many other depressants. Most users describe the subjective effects lasting somewhere around two to four hours, though deep sedation from a high dose can persist longer because the body’s clearance mechanisms become saturated at high concentrations, slowing elimination.
The fast clearance has practical consequences beyond the experience itself. In forensic and medical settings, GHB can become undetectable in blood within hours after ingestion, which is one reason it has been difficult to confirm in cases of suspected drug-facilitated assault. It is also why some users feel tempted to take another dose shortly after the first one wears off, which leads to perhaps the most common route to a GHB emergency.
Why Redosing Causes So Many Emergencies
A large proportion of GHB-related hospital visits involve people who did not take one large initial dose but instead “stacked” multiple doses over a session. A study of GHB overdose risk factors across users in the Netherlands found that the strongest predictor of coma was the lifetime number of times a person had used GHB, but right behind that were the number of doses taken in a single session (stacking) and using the drug alone without anyone nearby to intervene.5PubMed. Going knock-Recurrent comatose GHB intoxication in the Netherlands & Flanders (Belgium)
Users who had experienced an overdose most often attributed it to having taken more GHB than usual or having taken doses too close together.6European Addiction Research. Risk Factors of γ-Hydroxybutyrate Overdosing The problem is rooted in the drug’s pharmacokinetics. Because effects peak quickly and then drop off, a user might feel the first dose fading after an hour or so and decide to take a second. But if the first dose has not fully cleared, the second stacks on top of residual drug in the blood, pushing concentrations into the danger zone. The body eliminates GHB through saturable metabolic pathways, which means that doubling the dose does not simply double the blood level; it can raise it disproportionately because the clearance enzymes are already working at full capacity.
This makes GHB fundamentally different from, say, sipping a second beer when the first one is wearing off. With alcohol, the body clears a fairly predictable amount per hour and a second drink adds roughly a predictable increment. With GHB, a second dose taken too soon can produce a plasma spike far larger than either dose would have produced on its own. That nonlinear behavior is something even experienced users routinely misjudge.
Alcohol and Other Depressants Multiply the Risk
Combining GHB with alcohol is one of the most commonly reported circumstances in overdose cases, and the interaction is not simply additive. A controlled study that gave participants GHB and ethanol both individually and together found that the combination produced adverse events not seen with either drug alone, including episodes of low blood pressure and vomiting. Oxygen saturation in the blood dropped with each substance individually but dropped the most when both were on board simultaneously.7PubMed Central. GHB and Ethanol Effects and Interactions in Humans
Both GHB and alcohol depress the central nervous system, so using them together amplifies sedation, respiratory depression, and loss of protective reflexes like the gag reflex (which increases the risk of choking on vomit during unconsciousness). Other central nervous system depressants, such as benzodiazepines and opioids, pose similar risks when mixed with GHB. Because GHB is often used in social settings where alcohol is freely available, the combination is tragically common in emergency presentations. For anyone trying to gauge a “safe” dose of GHB, the presence of even a moderate amount of alcohol in the system effectively lowers that threshold in ways that are hard to predict.
How Tolerance Changes the Picture
Regular GHB users develop tolerance, meaning they need progressively higher doses to achieve the same subjective effects. This has been studied primarily in animal models. In one experiment, rats given repeated high doses of GHB over five consecutive days showed measurable changes in the drug’s effects on respiratory function, suggesting the body adapts to chronic exposure.8PubMed Central. Effect of Chronic γ-hydroxybutyrate (GHB) Administration on GHB-Induced Respiratory Depression Human evidence for tolerance is largely observational, but clinicians who treat GHB-dependent patients routinely report that chronic users consume doses that would be life-threatening for someone without tolerance, sometimes taking many grams every few hours around the clock.
Tolerance creates two distinct dangers. First, it pushes users toward higher doses, which narrows the already slim margin for error if they misjudge the concentration of a batch or take slightly more than intended. Second, tolerance can develop unevenly across different effects. A person might develop tolerance to the euphoric effects while the lethal dose does not shift upward by the same amount, meaning they chase a high that keeps requiring more drug while the amount needed to stop their breathing stays uncomfortably close.
If a tolerant user stops taking GHB abruptly, withdrawal can be severe, involving anxiety, tremors, insomnia, and in serious cases, delirium and seizures. The withdrawal syndrome resembles that of alcohol or benzodiazepines, which makes sense because all three act on overlapping brain systems. This pattern of escalating use, physical dependence, and dangerous withdrawal is part of why GHB dependence, while less common than dependence on alcohol or opioids, is considered a serious clinical problem when it does occur.
Your Body Already Makes GHB
One often-overlooked fact about GHB is that it is naturally present in the human body in trace amounts. It functions as a minor neurotransmitter and metabolic byproduct in the brain and other tissues. A recent placebo-controlled trial measured endogenous GHB concentrations in blood and found they ranged from about 0.007 to 0.050 micrograms per milliliter, with a median around 0.014 micrograms per milliliter.4PubMed Central. Endogenous Levels, Detection Time, and Symptoms of Gamma‐Hydroxybutyric Acid: Results From A Placebo‐Controlled Clinical Trial For context, the same trial found that after participants were given an oral dose of GHB, their peak blood concentrations jumped to a median of about 50 micrograms per milliliter, roughly 3,500 times higher than the natural baseline.
The existence of endogenous GHB matters for forensic science. After someone dies, natural GHB levels in the body can rise through post-mortem bacterial metabolism, sometimes reaching concentrations that could be confused with external administration. This makes it genuinely difficult in some forensic cases to determine whether GHB was taken as a drug or simply accumulated after death. Toxicologists use cutoff thresholds and contextual evidence to try to distinguish the two, but it remains one of the trickier questions in forensic toxicology.
Pharmaceutical GHB and Its Controlled Dosing
GHB is not exclusively an illicit substance. Under the brand name sodium oxybate, it is approved in several countries for treating narcolepsy with cataplexy. The pharmaceutical version is manufactured at a known, consistent concentration and prescribed in carefully controlled doses, typically starting low and titrated upward under medical supervision. Federal law in the United States reflects this dual identity: nonmedical GHB sits in Schedule I (the most restrictive category), while the FDA-approved pharmaceutical formulation is classified under Schedule III, recognizing its accepted medical use.
The existence of the pharmaceutical form underscores an important point about GHB’s pharmacology. It is not that the drug cannot be used with a predictable dose-response relationship; it can, when the concentration is standardized and the dose is measured precisely in milligrams. The danger specific to recreational use comes from the fact that illicit GHB has no standardized concentration, no measured dosing, and is often consumed alongside alcohol and other substances in uncontrolled settings. A person taking pharmaceutical sodium oxybate at a prescribed dose under a doctor’s supervision is operating in an entirely different risk category than someone sipping an unknown amount of homemade GHB from a water bottle at a party.
Measuring and Harm Reduction in Practice
For people who use GHB recreationally despite the risks, the single most important variable is knowing the concentration of the liquid they have. Without that information, any attempt to control the dose is guesswork. Some harm-reduction organizations suggest that users who cannot avoid the drug should at minimum use a milligram-accurate scale and a known-concentration source, start with a very small test amount, avoid mixing with alcohol or other depressants, space doses far apart, never use alone, and have someone sober present who knows how to call for emergency help. These steps do not make GHB safe, but they address the most common pathways to a fatal or near-fatal outcome.
The advice to avoid using alone is supported directly by the research. The study of recurrent comatose GHB intoxications in the Netherlands and Belgium identified solitary use as a strong independent risk factor for overdose coma.5PubMed. Going knock-Recurrent comatose GHB intoxication in the Netherlands & Flanders (Belgium) When a person loses consciousness alone, there is no one to position them on their side, monitor their breathing, or call an ambulance. Given that GHB can render someone deeply unconscious within minutes, and that breathing can slow dangerously during that unconsciousness, the absence of another person transforms a recoverable overdose into a potentially fatal one.
Stacking remains the other major preventable risk. Users who overdosed most often told researchers that they had taken more than their usual amount or dosed too close together.6European Addiction Research. Risk Factors of γ-Hydroxybutyrate Overdosing Setting a timer and committing to waiting a minimum interval before considering a second dose, while imperfect, directly targets the pharmacokinetic trap that causes so many emergencies. The nonlinear way GHB accumulates when clearance pathways are saturated means that even a modest second dose taken 90 minutes after the first can push blood levels into dangerous territory.